Vishwajit L Nimgaonkar1, Robert H Yolken, Tianxiu Wang, Chung-Chou H Chang, Lora McClain, Eric McDade, Beth E Snitz, Mary Ganguli. 1. Departments of *Psychiatry ∥Medicine ¶Neurology, University of Pittsburgh School of Medicine Departments of †Human Genetics §Biostatistics #Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA ‡Department of Pediatrics, Stanley Division of Neurovirology, Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: Numerous cross-sectional studies have related exposure to neurotropic infectious agents with cognitive dysfunction in older adults, however, the temporal sequence is uncertain. METHODS: In a representative, well-characterized, population-based aging cohort, we determined whether the temporal trajectories of multiple cognitive domains are associated with exposure to cytomegalovirus (CMV), Herpes Simplex virus, type 1 (HSV-1), Herpes Simplex virus, type 2 (HSV-2), or Toxoplasma gondii (TOX). Complex attention, executive functions, memory, language, and visuospatial function were assessed annually for 5 years among consenting individuals. Study entry IgG antibody titers indexing exposure to each infectious agent were examined in relation to slopes of subsequent temporal cognitive decline using multiple linear regressions adjusted for potential confounders. RESULTS: The IgG levels for HSV-2 were significantly associated with baseline cognitive domain scores (N=1022 participants). Further, the IgG levels for HSV-2, TOX, and CMV, but not HSV-1 were significantly associated with greater temporal cognitive decline that varied by type of infection. CONCLUSIONS: Exposure to CMV, HSV-2, or TOX is associated with cognitive deterioration in older individuals, independent of general age-related variables. An increased understanding of the role of infectious agents in cognitive decline may lead to new methods for its prevention and treatment.
BACKGROUND: Numerous cross-sectional studies have related exposure to neurotropic infectious agents with cognitive dysfunction in older adults, however, the temporal sequence is uncertain. METHODS: In a representative, well-characterized, population-based aging cohort, we determined whether the temporal trajectories of multiple cognitive domains are associated with exposure to cytomegalovirus (CMV), Herpes Simplex virus, type 1 (HSV-1), Herpes Simplex virus, type 2 (HSV-2), or Toxoplasma gondii (TOX). Complex attention, executive functions, memory, language, and visuospatial function were assessed annually for 5 years among consenting individuals. Study entry IgG antibody titers indexing exposure to each infectious agent were examined in relation to slopes of subsequent temporal cognitive decline using multiple linear regressions adjusted for potential confounders. RESULTS: The IgG levels for HSV-2 were significantly associated with baseline cognitive domain scores (N=1022 participants). Further, the IgG levels for HSV-2, TOX, and CMV, but not HSV-1 were significantly associated with greater temporal cognitive decline that varied by type of infection. CONCLUSIONS: Exposure to CMV, HSV-2, or TOX is associated with cognitive deterioration in older individuals, independent of general age-related variables. An increased understanding of the role of infectious agents in cognitive decline may lead to new methods for its prevention and treatment.
Authors: A M M Watson; K M Prasad; L Klei; J A Wood; R H Yolken; R C Gur; L D Bradford; M E Calkins; J Richard; N Edwards; R M Savage; T B Allen; J Kwentus; J P McEvoy; A B Santos; H W Wiener; R C P Go; R T Perry; H A Nasrallah; R E Gur; B Devlin; V L Nimgaonkar Journal: Psychol Med Date: 2012-09-14 Impact factor: 7.723
Authors: Allison E Aiello; Maryn Haan; Lynn Blythe; Kari Moore; Jeffrey M Gonzalez; William Jagust Journal: J Am Geriatr Soc Date: 2006-07 Impact factor: 5.562
Authors: Faith B Dickerson; John J Boronow; Cassie Stallings; Andrea E Origoni; Sara Cole; Bogdana Krivogorsky; Robert H Yolken Journal: Biol Psychiatry Date: 2004-03-15 Impact factor: 13.382
Authors: Michael M Vanyukov; Vishwajit L Nimgaonkar; Levent Kirisci; Galina P Kirillova; Maureen D Reynolds; Konasale Prasad; Ralph E Tarter; Robert H Yolken Journal: Dev Psychopathol Date: 2017-04-19
Authors: E G Severance; J Xiao; L Jones-Brando; S Sabunciyan; Y Li; M Pletnikov; E Prandovszky; R Yolken Journal: Int Rev Neurobiol Date: 2016-10-04 Impact factor: 3.230
Authors: Triptish Bhatia; Joel Wood; Satish Iyengar; Sreelatha S Narayanan; Ram Pratap Beniwal; Konasale M Prasad; Kehui Chen; Robert H Yolken; Faith Dickerson; Ruben C Gur; Raquel E Gur; Smita N Deshpande; Vishwajit L Nimgaonkar Journal: Schizophr Res Date: 2017-08-19 Impact factor: 4.939
Authors: Lance D Erickson; Dawson Hedges; Allison Stone; Bruce L Brown; Bradley Embley; Shawn D Gale Journal: Folia Parasitol (Praha) Date: 2022-05-16 Impact factor: 2.122
Authors: Kyrillos M Meshreky; Joel Wood; Kodavali V Chowdari; Martica H Hall; Kristine A Wilckens; Robert Yolken; Daniel J Buysse; Vishwajit L Nimgaonkar Journal: Psychiatry Res Date: 2019-07-31 Impact factor: 3.222
Authors: Rebecca C Stebbins; Grace A Noppert; Yang Claire Yang; Jennifer B Dowd; Amanda Simanek; Allison E Aiello Journal: Am J Epidemiol Date: 2021-05-04 Impact factor: 4.897